Research Topics
| Andreas KosterSummaryAffiliation: Deutsches Herzzentrum Berlin Country: Germany Publications
| Collaborators
|
Detail Information
Publications
A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II : adaptation of the ecarin clotting time to the act II deviceA Koster
Department of Anesthesiology, Deutsches Herzzentrum Berlin, Germany
J Thorac Cardiovasc Surg 119:1278-83. 2000..This requires monitoring of the ecarin clotting time. No commercial ecarin clotting time assay is available for clinical use. We adapted the ecarin clotting time to the easy-to-handle ACT II device...
Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results from the ARG-E03 trialAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany
J Thorac Cardiovasc Surg 132:699-700. 2006
Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the "EVOLUTION OFF" trialAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum, Berlin, Germany
Anesth Analg 103:540-4. 2006..These results suggest that bivalirudin, given according to the current protocol, provides reliable and effective anticoagulation during off-pump coronary artery bypass graft surgery...
Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin managementAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum, and Institute of Physiology, Freie Universitat, Berlin, Germany
Anesthesiology 97:837-41. 2002....
Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypassAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany
Anesth Analg 96:383-6, table of contents. 2003
Effects of tirofiban on hemostatic activation and inflammatory response during cardiopulmonary bypassAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany
Am J Cardiol 91:346-7. 2003
Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activationAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
J Cardiothorac Vasc Anesth 17:171-5. 2003..However, this poses a problem in patients insensitive to heparin. The present investigation was performed to assess different strategies of managing patients with heparin resistance during CPB...
An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro studyAndreas Koster
Department for Anesthesia, Deutsches Herzzentrum Berlin, Germany
Anesth Analg 96:1316-9, table of contents. 2003..Our data show that bivalirudin can be effectively eliminated via hemofiltration and plasmapheresis, although there were significant differences in the elimination rates among the filter systems investigated...
High antithrombin III levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypassAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Augustenburgerplatz 1, D-13353 Berlin, Germany
J Thorac Cardiovasc Surg 126:906-7. 2003
The more closed the bypass system the better: a pilot study on the effects of reduction of cardiotomy suction and passive venting on hemostatic activation during on-pump coronary artery bypass graftingAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany
Perfusion 20:285-8. 2005..However, further attenuation of hemostatic activation can be achieved by further closing the system and minimizing the blood/air interface by passive venting of the heart...
Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory responseAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum, Berlin, Germany
Anesth Analg 98:285-90, table of contents. 2004..This effect can most likely be attributed to the antifibrinolytic effects of aprotinin, as we did not observe effects on other variables of activation of the hemostatic/inflammatory system...
Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass graftingAndreas Koster
Department of Anesthesia, Deutsches Herrzentrum, Berlin, Germany
Am J Cardiol 93:356-9. 2004..Our data provide the first evidence of clinical feasibility of anticoagulation with bivalirudin during cardiopulmonary bypass...
Transfusion-free complex cardiac surgery with cardiopulmonary bypass in a 3.55-kg Jehovah's Witness neonateMichael Huebler
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany
Ann Thorac Surg 80:1504-6. 2005..55 kg Jehovah's Witness neonate boy...
Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot studyAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany
J Thorac Cardiovasc Surg 129:1391-4. 2005..This study was conducted to assess the effects of the currently suggested protocol for bivalirudin on hemostatic activation during cardiopulmonary bypass with and without cardiotomy suction...
The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigationAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Charite, Campus Virchow, Augustenburger Platz 1, 13353 Berlin, Germany
Anesth Analg 95:26-30, table of contents. 2002..IMPLICATIONS: During cardiopulmonary bypass, the plasma modified kaolin activated clotting time (ACT) provides a better correlation with heparin levels than the standard kaolin ACT...
Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patientsAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
Ann Thorac Surg 83:72-6. 2007..We assessed the occurrence of this disease and its influence on clinical outcome in patients after implantation of a ventricular assist device (VAD)...
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trialAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
Ann Thorac Surg 83:572-7. 2007....
In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgeryA Koster
Department of Anesthesia, Deutsches Herzzentrum, Berlin, Germany
J Clin Anesth 12:324-7. 2000..To assess the cross-reactivity of danaparoid sodium in patients undergoing cardiovascular surgery...
Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulantA Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin
Ann Thorac Surg 70:2160-1. 2000....
Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devicesA Koster
Department of Anesthesiology, Deutsches Herzzentrum Berlin, Augustenberger Platz 1, D 13353 Berlin, Germany
J Thorac Cardiovasc Surg 121:331-5. 2001..We analyzed the occurrence of HPF4/A and thromboembolism in patients with heparin-coated and noncoated VADs...
Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofibanA Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin Germany
Anesthesiology 94:245-51. 2001..The authors investigated a new concept using unfractionated heparins after platelet inhibition with the short-acting platelet glycoprotein IIb-IIIa antagonist tirofiban...
Effect of modified ultrafiltration on bivalirudin elimination and postoperative blood loss after on-pump coronary artery bypass grafting: assessment of different filtration strategiesAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum, Berlin, Germany
J Card Surg 23:655-8. 2008..We assessed the effect of four different strategies of modified ultrafiltration after cardiopulmonary bypass on the bivalirudin elimination and postoperative blood loss...
Extracorporeal elimination of large concentrations of tirofiban by zero-balanced ultrafiltration during cardiopulmonary bypass: an in vitro investigationAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany
Anesth Analg 99:989-92, table of contents. 2004..The subsidence coefficient b revealed no significant differences in elimination between the filter systems. These data suggest that ultrafiltration is an effective means for extracorporeal elimination of therapeutic levels of tirofiban...
High-dose aprotinin effectively reduces blood loss during on-pump coronary artery bypass grafting with bivalirudin anticoagulationAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum, Berlin, Germany
J Thorac Cardiovasc Surg 135:685-7. 2008
Evaluation of post-cardiopulmonary bypass coagulation disorders by differential diagnosis with a multichannel modified thromboelastogram: a pilot investigationA Koster
Department for Anesthesia, Deutsches Herzzentrum, Berlin, Germany
J Extra Corpor Technol 33:153-8. 2001..However, elaboration is desirable, and larger clinical trials are necessary for a final evaluation of the protocol...
Monitoring of bivalirudin anticoagulation during and after cardiopulmonary bypass using an ecarin-activated TEG systemAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum, Berlin, Germany
J Card Surg 23:321-3. 2008
Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HITAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany
Ann Thorac Surg 83:1865-7. 2007..Surgery was successfully performed with moderate intraoperative and postoperative blood loss and transfusion requirements...
Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgeryAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
J Thorac Cardiovasc Surg 133:1376-7. 2007
Some new perspectives in heparin-induced thrombocytopenia type IIA Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
J Extra Corpor Technol 33:193-6. 2001..Otherwise, the combination of UFH with a potent antiplatelet agent, especially with short-acting GP IIb/IIIa antagonists, is an attractive alternative...
Assessment of the resonance thromboelastograph CS-3 for differentiation of coagulation disorders: a pilot in vitro investigation of simulated post-cardiopulmonary bypass coagulopathiesA Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
J Extra Corpor Technol 33:159-66. 2001..Further improvement may be achieved using a modified RTG by adding plasma coagulation factors in one channel for an improved evaluation of platelet function, even under the condition of a loss of procoagulants...
Regional differences in tissue oxygenation during cardiopulmonary bypass for correction of congenital heart disease in neonates and small infants: relevance of near-infrared spectroscopyMathias Redlin
Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany
J Thorac Cardiovasc Surg 136:962-7. 2008..Moreover, we evaluated potential benefits of near-infrared spectroscopic monitoring of regional tissue oxygenation...
Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodiesMichael Huebler
Department of Cardiothoracic and Vascular Surgery, Deutsches Herssentrum Berlin, Germany
J Card Surg 21:286-8. 2006..The postoperative course was uneventful and the patient was discharged from hospital after 5 days. CONCLUSION: Bivalirudin can be safely used for anticoagulation during CPB even in complex cardiac surgery...
Repair of ALCAPA in a 4-kg patient followed by successful weaning and "off-pump" explantation of an apical venting pulsatile LVADMichael Huebler
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Germany
J Card Surg 20:261-3. 2005..The present case demonstrates successful weaning and complete removal of an apical venting pulsatile LVAD in a 4-kg infant without the employment of CPB...
Transfusion-free cardiopulmonary bypass in Jehovah's Witness patients weighing less than 5 kgWolfgang Boettcher
Department of Clinical Perfusion, Academy for Perfusion, Deutsches Herzzentrum Berlin, Berlin, Germany
J Extra Corpor Technol 37:282-5. 2005..5 g/dL. The hemoglobin concentrations measured during CPB ranged from 5.9 to 6.5 g/dL, 6.4 to 6.8 g/dL, and 5.5 to 5.9 g/dL, respectively. The patients did not receive any blood or blood products during their entire hospital stay...
Transfusion-free cardiac reoperation in an 11-kg Jehovah's Witness child by use of a minimized cardiopulmonary bypass circuitMichael Huebler
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum, D 13353 Berlin, Germany
Tex Heart Inst J 34:108-11. 2007..The goal of safe, transfusion-free surgery was achieved chiefly by minimizing the priming volume of the cardiopulmonary bypass circuit to 200 mL while providing adequate flow and standard safety features...
Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist deviceBrigitte Stiller
Department of Pediatric Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
Intensive Care Med 30:1814-20. 2004..We compared the coagulation disorders and the need for blood products in children treated either with extracorporeal membrane oxygenation (ECMO) or with the Berlin Heart pulsatile pneumatic ventricular assist device...
Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new scoreHarald Hausmann
Deutsches Herzzentrum Berlin, Berlin, Germany
Circulation 106:I203-6. 2002..Nevertheless, indications for and timing of the implantation of a VAD in patients who have received an intra-aortic balloon pump (IABP) remain unclear...
Experience with over 1000 implanted ventricular assist devicesEvgenij V Potapov
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Germany
J Card Surg 23:185-94. 2008..The use of ventricular assist devices (VADs) in patients with chronic end-stage or acute heart failure has led to improved survival. We present our experience since 1987...
Transfusion-free cardiac surgery with cardiopulmonary bypass in a 2.2-kg neonateMichael Hubler
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany
J Card Surg 20:180-2. 2005....
Transfusion-free arterial switch operation in a 1.7-kg premature neonate using a new miniature cardiopulmonary bypass systemMichael Huebler
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Germany
J Card Surg 23:358-60. 2008..Stringent improvement of these strategies, particularly the downsizing of the cardiopulmonary bypass system, have now enabled a transfusion-free arterial switch operation in a 1700-gram prematurely born neonate...
Hybrid approach facilitates use of a minimized CPB circuit and transfusion free surgery in an extended Norwood stage II procedureMichael Huebler
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany
J Card Surg 22:508-10. 2007....
The MicroMed DeBakey VAD--part II: Impact on the hemostatic systemsThomas Fischer
Department of Anesthesia, Deutsches Herzzentrum, Berlin, Germany
J Extra Corpor Technol 35:284-6. 2003
The MicroMed DeBakey VAD--part I: The pump and the blood flowEvgenij V Potapov
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum, Berlin, Germany
J Extra Corpor Technol 35:274-83. 2003....
Detection of lower torso ischemia by near-infrared spectroscopy during cardiopulmonary bypass in a 6.8-kg infant with complex aortic anatomyMathias Redlin
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
Ann Thorac Surg 82:323-5. 2006..This shows that parallel near-infrared spectroscopy of the brain and the lower extremities may represent a novel non-invasive monitoring technique to ensure adequate cerebral and extracerebral perfusion during cardiopulmonary bypass...
Perfusion technique for nonhaemic cardiopulmonary bypass prime in neonates and infants under 6 kg body weightFrank Merkle
Academy for Perfusion, Deutsches Herzzentrum Berlin, Berlin, Germany
Perfusion 19:229-37. 2004..The degree of haemodilution and, thus, the requirements for blood transfusion may be reduced when the CPB circuit is miniaturized without compromising patient safety...
Safe minimization of cardiopulmonary bypass circuit volume for complex cardiac surgery in a 3.7 kg neonateWolfgang Boettcher
Department of Perfusion, Deutsches Herzzentrum Berlin, Germany
Perfusion 18:377-9. 2003..We report on our efforts to minimize the CPB system and adjust the perfusion strategy to the goal of transfusion-free CPB in a 3.7 kg neonate scheduled for repair of transposition of the great arteries...
Bloodless surgery of acute type A aortic dissection in a Jehovah's Witness patientMiralem Pasic
Deutsches Herzzentrum Berlin, Berlin, Germany
Ann Thorac Surg 80:1507-10. 2005..We combined the normothermic cross-clamping technique with a blood conservation strategy...
Management of protamine allergy with bivalirudin during coronary artery revascularizationAndreas Koster
Department of Anesthesia, Herzzentrum Lahr Baden, Lahr, Germany
Ann Thorac Surg 90:276-7. 2010..Instead, complete coronary artery revascularization was successfully performed off-pump using bivalirudin as the anticoagulant...
Effects of unfractionated heparin, low molecular weight heparin and r-hirudin on leukocyte adhesion in ischemia/reperfusionHelmut Habazettl
Department of Physiology, Charite, Campus Benjamin Franklin, Berlin, Germany
Blood Coagul Fibrinolysis 15:375-81. 2004..This effect may contribute to the benefits of direct thrombin inhibitors seen in clinical studies after treatment for acute coronary syndromes...
Inhaled milrinone attenuates experimental acute lung injuryMoritz Bueltmann
Department of Anesthesiology, German Heart Institute, Berlin, Germany
Intensive Care Med 35:171-8. 2009..To test whether inhalation of the phosphodiesterase 3 inhibitor milrinone may attenuate experimental acute lung injury (ALI)...
Reduction of microemboli count in the priming fluid of cardiopulmonary bypass circuitsFrank Merkle
Academy for Perfusion, Department of Surgery, Deutsches Herzzentrum, Berlin, Germany
J Extra Corpor Technol 35:133-8. 2003..5 microm and 3 microm may be explained by a possible filtering capacity of membrane oxygenators. The 0.2 microm PBF is an effective tool to reduce the particle load in the CPB priming fluid...
Factors influencing results and outcome after transmyocardial laser revascularizationThomas Krabatsch
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Germany
Ann Thorac Surg 73:1888-92. 2002..Because this operation is associated with significant morbidity and mortality, it is important to select patients for TMR who are likely to benefit from the procedure...
Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failureThomas Hentschel
Department of Anesthesiology, German Heart Institute Berlin, Institute of Physiology, Charite Universitaetsmedizin Berlin, Campus Benjamin Franklin, Germany
Anesthesiology 106:124-31. 2007....
Bivalirudin anticoagulation during cardiac surgery: a single-center experience in 141 patientsA Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
Perfusion 24:7-11. 2009..Recent problems associated with the production of heparin have emphasized the urgent need for an alternative for use beyond the limited indication of heparin-induced thrombocytopenia...
Predictors of survival 1 hour after implantation of an intra-aortic balloon pump in cardiac surgeryH Hausmann
Deutsches Herzzentrum Berlin, Department of Cardiothoracic and Vascular Surgery, Germany
J Card Surg 16:72-77; discussion 78. 2001..In patients with low-output syndrome despite IABP support, implantation of a ventricular assist system should be considered...
Pulsatile flow in patients with a novel nonpulsatile implantable ventricular assist deviceE V Potapov
Deutsches Herzzentrum Berlin, Berlin, Germany
Circulation 102:III183-7. 2000..To detect the flow in peripheral vessels, we measured transcranial Doppler signals in patients after implantation...
Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADsE V Potapov
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany
J Heart Lung Transplant 20:1310-6. 2001....
Correction of congenital heart defects in Jehovah's Witness childrenV Alexi-Meskishvili
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany
Thorac Cardiovasc Surg 52:141-6. 2004..6) and at discharge it was 7.1 - 14.5 g/dl (mean 15.5). No blood or blood products were used in any patient. CONCLUSION: Bloodless cardiac surgery with and without CPB can be safely performed in Jehovah's Witness infants and children...
[Coronary artery bypass grafting in patients with highly impaired ventricular function. Long-term outcome]H Hausmann
Abteilung für Herz, Thorax und Gefasschirurgie, Deutsches Herzzentrum Berlin, Germany
Dtsch Med Wochenschr 127:2503-7. 2002..In our study we investigated, how preoperative ventricular dysfunction influences long term survival after coronary bypass surgery...
Floating nonocclusive thrombus in the ascending aortaRalf Sodian
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Germany
Ann Thorac Surg 74:588-90. 2002..In our judgment, a floating mass in the ascending aorta represents an emergency and should be removed before major thromboembolic complications occur...
Transcranial detection of microembolic signals in patients with a novel nonpulsatile implantable LVADE V Potapov
Department of Cardiothoracic and Vascular Surgery, German Heart Institute, Berlin
ASAIO J 47:249-53. 2001..In one patient with preoperatively noted MES the prevalence of MES postoperatively was 50%. The high speed rotating impeller of the DeBakey VAD did not produce any detectable microthrombi or bubbles from cavitation effects...
Autologous plasma and platelet sequestration at the beginning of cardiopulmonary bypass: a pilot investigation in five patients undergoing extended vascular surgery in deep hypothermiaA Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
ASAIO J 48:106-9. 2002..The data presented provide evidence that autologous plasma and platelet sequestration during CPB initiation is effective. The harvested material reveals a high platelet count and fibrinogen level and preserves functional integrity...
Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor deviceM Loebe
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Germany
ASAIO J 47:272-4. 2001..Further investigations are necessary for evaluation of the pathophysiologic mechanism and clinical implications of these findings...
The direct thrombin inhibitor argatroban: a review of its use in patients with and without HITAndreas Koster
Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany
Biologics 1:105-12. 2007..Additionally, data from clinical trials with argatroban use outside HIT, in more special indications such as in percutaneous coronary intervention, stroke, renal replacement therapy, and intensive care medicine, are reviewed...
Specific p38 inhibition in stimulated endothelial cells: a possible new anti-inflammatory strategy after hypothermia and rewarmingAntje Diestel
Department of Pediatric Cardiology, Charite Universitaetsmedizin, Berlin, Germany
Vascul Pharmacol 51:246-52. 2009..Therefore inhibition of p38 or components of the p38 pathway could be a promising and selective antiinflammatory therapeutic target after hypothermic CPB...
Bivalirudin: a reviewTheodore E Warkentin
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Expert Opin Pharmacother 6:1349-71. 2005..Anecdotal 'off-label' experience for the treatment of heparin-induced thrombocytopenia shows promise...
Impact of heparin management on release of tissue factor pathway inhibitor during cardiopulmonary bypassThomas Fischer
Anesthesiology 100:1040. 2004
BivalirudinTheodore E Warkentin
Department of Pathology and Molecular Medicine, Michael G DeGroote School of Medicine, McMaster Unniversity, Hamilton, Ontario, L8L 2X2 Canada
Thromb Haemost 99:830-9. 2008....
Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopeniaCornelius M Dyke
Department of Surgery and Anesthesiology, Gaston Memorial Hospital, Gastonia, North Carolina, USA
Ann Thorac Surg 80:299-303. 2005..The novel short-acting, direct-thrombin inhibitor bivalirudin is the only alternative to heparin/protamine being used in elective non-HIT patients during CPB...
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Theodore E Warkentin
Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, 237 Barton Street E, Hamilton, Ontario, Canada
Chest 133:340S-380S. 2008..For patients receiving VKAs at the time of diagnosis of HIT, we recommend use of vitamin K (10 mg po or 5 to 10 mg IV) [Grade 1C]...
Case 1-2006: off-pump coronary artery bypass graft surgery anticoagulation with bivalirudin: a patient with heparin-induced thrombocytopenia syndrome type II and renal failureBruce D Spiess
Department of Anesthesiology, Virginia Commonwealth University Health System, Richmond, VA 23298-0695, USA
J Cardiothorac Vasc Anesth 20:106-11. 2006
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON studyCornelius M Dyke
Carolina Cardiovascular and Thoracic Surgery Associates, Gaston Memorial Hospital, Gastonia, NC 28056, USA
J Thorac Cardiovasc Surg 131:533-9. 2006..This trial was performed to evaluate the safety and efficacy of bivalirudin as an alternative to heparin with protamine reversal in on-pump cardiac surgery...
Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF studyNicholas G Smedira
Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
J Thorac Cardiovasc Surg 131:686-92. 2006..This trial was performed to evaluate the safety and efficacy of bivalirudin in off-pump coronary artery bypass grafting...
Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effectiveGeorge J Palmer
Florida Hospital Cardiovascular Institute, Orlando, Florida, USA
Heart Surg Forum 11:E24-9. 2008..This is evidenced by low hospital mortality and morbidity rates. Further follow-up is warranted to discern the influence of bivalirudin on long-term clinical outcomes...
Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgeryMarcia L Zucker
Clinical Affairs, ITC, Edison, New Jersey 07039, USA
J Extra Corpor Technol 37:364-8. 2005..The ACTT assay is sensitive to levels of bivalirudin and may offer a simple method for monitoring bivalirudin during cardiac surgery...
Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodiesCornelius M Dyke
Department of Cardiovascular and Thoracic Surgery, Gaston Memorial Hospital, Gastonia, North Carolina 28054, USA
Ann Thorac Surg 84:836-9. 2007....
Assessing errors in the determination of base excessAlexander Mentel
Department of Anesthesiology and Intensive Care Medicine, Kraukenaustalten Gilead, Von Bodelschwinghsche Anstalten Bethel, Bielefeld, Germany
Anesth Analg 94:1141-8, table of contents. 2002..This variability is attributable to multiple factors, including lack of correction for deoxygenated hemoglobin (Haldane effect)...
